HomeInsightsResults

Ganga Pharmaceuticals Ltd Quarterly Result

Ganga Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 18, 2024)

stocks purchased

8.0 K

Stocks Traded

(Nov 18, 2024)

Last Updated on: Nov 23, 2024

Image

Ganga Pharmaceuticals Ltd

NSE: GANGAPHARMA

Net Profit

₹ 0.02

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Ganga Pharmaceuticals Ltd for the Sep '24 is ₹ 1.6 crore as compare to the Jun '24 revenue of ₹ 0 crore. This represent the growth of Infinity%.
  • The ebitda of Ganga Pharmaceuticals Ltd for the Sep '24 is ₹ 0.18 crore as compare to the Jun '24 ebitda of ₹ 0 crore. This represent the growth of Infinity%.
  • The net profit of Ganga Pharmaceuticals Ltd for the Sep '24 is ₹ 0.02 crore as compare to the Jun '24 net profit of ₹ 0 crore. This represent the growth of Infinity%.

Results Analysis

Market Price of Ganga Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Ganga Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
18 Nov 202415
07 Oct 202415.73
04 Oct 202415.73
16 Sep 202419.57
26 Aug 202419.57
16 Aug 202421.68
14 Aug 202427.1
13 Aug 202425.4
09 Aug 202424.9
07 Aug 202425

Historical Revenue of Ganga Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Ganga Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Ganga Pharmaceuticals Ltd

No data available

* All values are in crore

Ganga Pharmaceuticals Ltd News Hub

News

Ganga Pharmaceuticals schedules board meeting

Ganga Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 No...

Read more

06 Nov 202413:58

News

Ganga Pharmaceuticals to hold AGM

Ganga Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

09 Aug 202414:59

News

Ganga Pharmaceuticals to table results

Ganga Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...

Read more

06 May 202416:24

News

Ganga Pharmaceuticals EGM scheduled

Ganga Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

06 Dec 202319:01

News

Ganga Pharmaceuticals to coonsider fund raising

Ganga Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 4 De...

Read more

28 Nov 202310:54

News

Ganga Pharmaceuticals to declare Quarterly Result

Ganga Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 No...

Read more

30 Oct 202318:23

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Ganga Pharmaceuticals Ltd Quarterly Result

What is the EPS of Ganga Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Ganga Pharmaceuticals Ltd is 0.1. An EPS is the amount of net income attributed to each share of a common stock.

How is Ganga Pharmaceuticals Ltd EPS calculated?

The EPS of Ganga Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Ganga Pharmaceuticals Ltd report its EPS?

Ganga Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Ganga Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Ganga Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Ganga Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Ganga Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*